THE IMPACT OF PD-1+ INNATE-LIKE CD8+T CELLS ON THE HBSAG REDUCTION IN ACTIVE CHRONIC HEPATITIS B PATIENTS RECEIVING NUCLEOS(T) IDE ANALOGUE THERAPY

被引：0
作者：
Jeng, Rachel Wen-Juei [1 ]
Huang, Hsiang-Wei [1 ]
Lin, Chia-Wei [1 ]
Fan, Jian He [1 ]
Liu, Yen-Chun [1 ]
Ku, Wei-Ting [1 ]
Wu, Cheng-Heng [1 ]
Huang, Chien-Hao [2 ]
Lin, Yung-Chang [1 ]
Lin, Chun Yen [1 ]
机构：
[1] Chang Gung Mem Hosp, Linkou Med Ctr, Taoyuan, Taiwan
[2] Chang Gung Univ, Taoyuan, Taiwan
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
996
引用
收藏
页码：S755 / S756
页数：2
相关论文
共 50 条
[1]   Adherence to nucleos(t)ide Analogue Therapy in Patients With Chronic Hepatitis B [J].
Manolakopoulos, Spilios ;
Goulis, John ;
Striki, Athanasia ;
Deutsch, Melanie ;
Perlepe, Nikoleta ;
Triantos, Christos ;
Papatheodoridis, George V. .
GASTROENTEROLOGY, 2015, 148 (04) :S1068-S1068
[2]   KINETICS OF QUANTITATIVE HBsAg DECLINE IN CHRONIC HEPATITIS B PATIENTS RECEIVING NUCLEOS( T) IDE ANTIVIRAL THERAPY [J].
Hyun, Yong Gyu ;
Fung, Scott K. .
HEPATOLOGY, 2023, 78 :S432-S433
[3]   Dynamic change in HBsAg in chronic hepatitis B patients receiving nucleos(t)ide analogues in China [J].
Shu, Meng ;
Teng, Jiaming ;
Dong, Sijia ;
Zhang, Yongjing ;
Qiu, Hong ;
Cai, Wei .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 :241-241
[4]   Association of nucleos(t)ide analogue therapy with Parkinson disease in chronic hepatitis B patients [J].
Lim, Jihye ;
Lee, Hyo Young ;
Sang, Hyunji ;
Jeong, Su Jin ;
Kim, Ha Il .
SCIENTIFIC REPORTS, 2025, 15 (01)
[5]   Outcome of chronic hepatitis B patients who discontinued nucleos(t)ide analogue therapy [J].
Yapali, Suna ;
Oberhelman, Kelly ;
Lok, Anna S. .
HEPATOLOGY, 2014, 60 :1114A-1115A
[6]   Interruption of nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B - a new concept to achieve HBsAg reduction? [J].
Siederdissen, C. Hoener Zu ;
Rinker, F. ;
Falk, C. S. ;
Filmann, N. ;
Maasoumy, B. ;
Deterding, K. ;
Port, K. ;
Herrmann, E. ;
Wedemeyer, H. ;
Manns, M. P. ;
Kraft, A. R. ;
Cornberg, M. .
JOURNAL OF VIRAL HEPATITIS, 2015, 22 :50-50
[7]   Hepatitis B Virus-Specific T Cells as a Biomarker for Discontinuation of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B [J].
Tian, Yongjun ;
Ou, Jing-hsiung James .
HEPATOLOGY, 2019, 69 (03) :1342-1344
[8]   Impact of Nucleos(t)ide Analogue Combination Therapy on the Estimated Glomerular Filtration Rate in Patients With Chronic Hepatitis B [J].
Qi, Xun ;
Wang, Jinyu ;
Chen, Liang ;
Huang, Yuxian ;
Qin, Yanli ;
Mao, Richeng ;
Zhang, Jiming .
MEDICINE, 2015, 94 (15)
[9]   HBsAg decline after interrupting nucleos(t)ide analogue therapy in HVeAg-negative chronic hepatitis B [J].
Siederdissen, C. Hoener zu ;
Rinker, F. ;
Falk, C. S. ;
Filmann, N. ;
Maasoumy, B. ;
Deterding, K. ;
Port, K. ;
Mix, C. ;
Herrmann, E. ;
Wedemeyer, H. ;
Manns, M. P. ;
Kraft, A. R. M. ;
Cornberg, M. .
JOURNAL OF CLINICAL VIROLOGY, 2015, 69 :233-233
[10]   Effect of Nucleos(t)ide Analogue Therapy on Risk of Intrahepatic Cholangiocarcinoma in Patients With Chronic Hepatitis B [J].
Lee, Teng-Yu ;
Hsu, Yao-Chun ;
Yu, Shi-Hang ;
Lin, Jaw-Town ;
Wu, Ming-Shiang ;
Wu, Chun-Ying .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (06) :947-+
12345